Ultrasensitive plasmon enhanced Raman scattering detection of nucleolin using nanochannels of 3D hybrid plasmonic metamaterial
Cai-Feng Shi,Zhong-Qiu Li,Chen Wang,Jian Li,Xing-Hua Xia
DOI: https://doi.org/10.1016/j.bios.2021.113040
IF: 12.545
2021-04-01
Biosensors and Bioelectronics
Abstract:<p>Detection of cancer biomarker is of great significance in cancer diagnostics. In this work, we propose an ultrasensitive and <em>in situ</em> method for plasmon enhanced Raman scattering (PERS) detection of nucleolin (NCL) using a 3D hybrid plasmonic metamaterial (PM). In this aptasensor, thiolated complementary DNA (cDNA) immobilized on PM can hybridize with Rox-labeled NCL-binding aptamer (AS1411-Rox) to form a rigid double-stranded DNA (dsDNA). When NCL passes through the PM nanochannels under a transmembrane voltage bias, it interacts with AS1411-Rox to form G-quadruplexes (G4-AS1411-Rox), resulting in the release of AS1411-Rox from the nanochannels surface and the decrease in PERS signal of the reporter Rox. This change in PERS signals can be recorded <em>in situ</em> without the interference of external environment. With the help of the enrichment function of nanochannel, the present method is able to achieve fast NCL detection within 10 min with a detection limit as low as 71 pM. Furthermore, our method shows excellent specificity, reversibility, uniformity (relative standard deviation of ∼6.86%) and reproducibility (∼6.65%), providing a new platform for reliable cancer auxiliary diagnosis and drug screening.</p>
biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop an ultrasensitive method for in - situ detection of nucleolin (NCL). Nucleolin is a protein over - expressed in a variety of human diseases, especially in certain types of cancers, such as colon cancer, breast cancer and lung cancer. Therefore, the development of an NCL detection method with high sensitivity, specificity and stability is of great significance for the early diagnosis and treatment monitoring of cancer.
The paper proposes a surface - enhanced Raman scattering (Plasmon Enhanced Raman Scattering, PERS) method based on three - dimensional hybrid plasmonic metamaterial (3D hybrid plasmonic metamaterial, PM) for the detection of NCL. By introducing an electric field in the PM nano - channels, rapid enrichment of NCL can be achieved, and through specific molecular recognition interactions, the release of the reporter molecule Rox is caused, thereby resulting in a change in the PERS signal. This method can not only achieve ultrasensitive detection of NCL, but also has good selectivity, reusability, uniformity and reproducibility, providing a new platform for reliable cancer - assisted diagnosis and drug screening.